Fusion CEO Talks AZ Deal Making And Canada’s Blossoming Biotech Ecosystem

Fusion Pharmaceuticals Inc CEO John Valliant talked to In Vivo about Canadian leadership in radiopharmaceutical innovation, its differentiated approach, and excitement around combination therapies for precision cancer treatments.